TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

Glucocorticoids are widely used to treat patients with autoimmune diseases such as systemic lupus erythematosus (SLE)1,2. However, regimens used to treat many such conditions cannot maintain disease control in the majority of SLE patients and more aggressive approaches such as high-dose methylpredni...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Guiducci, Cristiana, Gong, Mei, Xu, Zhaohui, Gill, Michelle, Chaussabel, Damien, Meeker, Thea, Chan, Jean H., Wright, Tracey, Punaro, Marilynn, Bolland, Silvia, Soumelis, Vassili, Banchereau, Jacques, Coffman, Robert L., Pascual, Virginia, Barrat, Franck J.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964153/
https://ncbi.nlm.nih.gov/pubmed/20559388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature09102
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki